Chris JacobsSell
BioLife Solutions, Inc. · Transaction Dec 12, 2022 · Filed Jan 20, 2023 · $1,001 to $15,000
NASDAQ NMS - GLOBAL MARKET · BLFS
0.00% · $0.0000 · Vol Not reported
Market closed · last close shown
BioLife Solutions Inc
Life Sciences Tools & Services
$36.78
Follow $BLFS
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $BLFS by emailVeridion Score
BETAHIGH CONF · 6 of 6 factors measuredThu Oct 1 · last completed session · Pre-market · regular session opens 9:30 ET · BLFS
MethodologyBLFS
BioLife Solutions Inc
Thu Oct 1 · last completed session · Pre-market · regular session opens 9:30 ET
Middle range
Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
57/ 100
Veridion Score
Middle range · HIGH confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6 of 6 factors measured · Thu Oct 1 · last completed session · Pre-market · regular session opens 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is BLFS moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About BioLife Solutions Inc
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUSListed since
1989
Employees
155
Country
US
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$36.78
Last session
Day high
$36.78
Last session
Day low
$36.78
Last session
Previous close
$36.78
52W high
$39.22
-6.22% from high
52W low
$18.15
88% of range
Market cap
$1.8B
P/E
32.78×
EPS
$1.18
Beta
0.71
Shares out
48.9M
Avg volume
924.8K
VWAP
$36.78
Last session
Price history computed in-house
1W
-4.44%
1M
+2.39%
3M
+30.84%
1Y
+41.95%
YTD
+52.11%
SMA 50 $35.39 · above
SMA 200 $26.49 · above
52W position 88%
BLFS overview
Related filings and maps
Public disclosures
Congress activity in BLFS
Official filing ↗
Chris JacobsBuy
BioLife Solutions, Inc. · Transaction Nov 8, 2022 · Filed Dec 12, 2022 · $1,001 to $15,000
Federal contracts
BLFS contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for BLFS in this window.
Lobbying spend
BLFS lobbying filings, year to date.
Registered lobbying filings matched to BioLife Solutions Inc.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for BLFS in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for BLFS.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.